Global cell expansion technologies market size was around US$13.5 Bn in 2021, and it is projected to grow at a CAGR of 12% during the forecast period.
Rising Chronic Disease Prevalence Remains the Primary Growth Influencer for Cell Expansion Technologies Market
Cell expansion fundamentally refers to a cell's capacity to steadily extend its surface area while growing. For the wall to stretch and expand in size, fresh cell wall material must typically be synthesized, and the wall must be carefully loosened. Key players in this process are cell-wall-associated proteins from the so-called expansion family. Numerous hospitals, biotech and pharmaceutical firms, academic and research institutions, and other organizations frequently use cell expansion. In contrast to the growing demand for regenerative medicine, which provides effective results for patients, the rising prevalence of chronic diseases such as cancer, diabetes, and osteoarthritis, as well as the high demand for drug screening tools, and medical research purposes are the key factors driving the growth of the cell expansion technologies market. The expanding initiatives and investments made by the government and commercial sector in R&D projects also contribute to the market's overall growth. The market expansion is hampered by the scarcity of qualified professionals and high setup costs.
Cell expansion technologies market is anticipated to benefit from technological progress and product innovation in cell expansion fuel. On the other hand, the lack of advanced instruments and 3D cell expansion technologies could threaten the market's progress. Cell-based research is increasingly being conducted, which is one of the main factors driving the market for cell expansion. Another important aspect is the rising prevalence of chronic diseases. Worldwide, cardiovascular disease (CVD) is the leading cause of death. According to the WHO, 17.9 million deaths worldwide in 2016 were attributed to CVD or 31% of all fatalities. The number of cancer patients is rising, creating a large patient pool and an opportunity for manufacturers to tap into and profit from the market. Thus, it is projected that there will be a rise in the cases of chronic diseases.
COVID-19 Impact on Cell Expansion Technologies Market
Mesenchymal stromal cells (MSCs), in particular, present a viable method for reducing the negative effects of the COVID-19 infection. Cell-based methods. In COVID-19 patients, this treatment has been demonstrated to improve tissue healing and decrease the expression of pro-inflammatory cytokines. Since the COVID-19 outbreak, 27 clinical investigations of MSC-based cell therapy techniques have started in China, along with an increasing number of university and industrial trials overseas, according to the WHO ICTRP and the NIH ClinicalTrials.gov databases. One of the main uses of cell expansion is in stem cell and regenerative medicine research. This is a key sign of market expansion because the COVID-19 trial indicates that stem cell-based medicines have a lot of potential.
Cell Therapy Techniques Usage in Different Areas to Drive Cell Expansion Technologies Market Growth
Profitable opportunities are opening up in the cell expansion technologies market due to the growing usage of cell therapy techniques to create pharmaceuticals, vaccines, antibiotics, and therapies. Furthermore, it is predicted that throughout the forecast period, the growth of the biopharmaceutical industry will aid in market expansion.
Ethical Issues with Cell Biology Research to Hamper Cell Expansion Technologies Market Growth
Animal and human cells are utilized in gene therapy studies that involve the recombination of genes and stem cell research therapies, making the use of both species necessary for study in cell biology. These cells are also utilized to investigate the toxicity and pharmacokinetics of medications that may be harmful to both people and animals in vivo. Additionally, human embryos are frequently destroyed in stem cell research trials that employ them for medicinal purposes. Strict rules have been developed by moral authorities in numerous nations across the world to oversee these activities. Cell biology research is subject to strict regulations that have been put in place by organizations including the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. Cell biology research is being severely constrained in many nations worldwide due to these ethical issues and regulations on using cells for study. In consequence, it is anticipated that this will limit the market for cell expansion's expansion.
High Demand During Development of Regenerative Medicine to Drive Consumable Sector in Cell Expansion Technologies Market
It is expected to continue to hold a strong position throughout the forecast years. The consumables sector has the greatest market share, primarily due to the high demand during the development of regenerative medicine and the expansion of stem cell research in the biopharmaceutical industry. The substantial revenue share of this category is attributed to the availability of a broad selection of commercial media and reagent items tailored to particular types of cells. These goods are also readily available, ready to use and come in formulas without serum.
Rising Governmental and Private Sector Investments in Human Cell Research to Drive Growth for Human Cell Category in Cell Expansion Technologies Market
The human cells market category held a greater market share, mostly due to rising governmental and private sector investments in human cell research, expanding uses for human stem cells, and an increase in the prevalence of diseases like cancer. Since differentiated human cells serve a specific purpose in the body, they contributed significantly to revenue share. Differentiated cells, like fibroblasts, have become extremely important in the healing of cutaneous wounds and skin bioengineering, supporting segment growth. Stem cells and developed cells are included in the section on human cells. Adult stem cells, ESCs, and iPSCs are subcategories of the stem cells market category.
Rising Incidence of Cancers to Drive Cell Expansion Technologies Market in North America
Over the forecast period, it is anticipated that the North American’s cell expansion technologies market will account for the largest revenue share. The significant market share of this sector is primarily explained by the rising incidence of cancer, rising government funding, rising stem cell therapy research activities, growing public awareness of advanced treatment options, rising geriatric population, and the significant presence of industry players in the area. Due to increased government funding initiatives that have sped up the production of stem cells and the development of regenerative medicine and cellular therapy products, the region will maintain its leadership position over the coming years. This, in turn, fuels this region's desire for cell expansion platforms. For instance, the Southwest Research Institute (SwRI) received USD 5.3 million in financing from the FDA and the Medical Technology Enterprise Consortium (MTEC) in October 2019. (US). The SwRI used these monies to propagate cells for the creation of individualized regenerative medicine. These investments increase the region's ability to generate income.
The development of biopharmaceuticals is further fueled by the entry of new biopharmaceutical businesses and the spread of bioprocessing technology, which in turn strengthens the expansion processes used during bioproduction. Additionally, single-use technologies are rapidly gaining ground in the production of cellular therapies on a commercial scale. Alternative planar cell expansion techniques have been introduced over time, including small multi-layer bioreactors. This met the criteria for closed systems, which restrict the hazards of contamination while maintaining control over a sizable upstream production and unit production. These all factors are also driving cell expansion technologies market for cell expansion technologies in North America region in the forecasted period.
The Asia Pacific cell expansion technologies market is anticipated to experience stable revenue growth throughout the forecast period due to increased efforts made by numerous local pharmaceutical and biotechnology businesses to develop and market their cellular therapies; the Asia Pacific is anticipated to see the quickest growth throughout the forecast period. Due to ongoing economic growth and healthcare infrastructure expansion. Furthermore, because of its rapid economic development and cheap operational costs, Asia Pacific will grow at the highest rate throughout the projection period and present lucrative prospects for key players in the cell expansion technologies market.
Global Cell Expansion Technologies Market: Competitive Landscape
In March 2020, The Life Sciences division of General Electric Company sold the Biopharma business to Danaher. Within Danaher's Life Sciences business, the division will operate independently under Cytiva. Moreover, in May 2020, The German company Eppendorf Group is increasing the size of its industrial facility in Oldenburg, Holstein. The business will produce consumables made of high-quality plastic, like pipette tips and tubes and single-use bioreactor vessels, at the recently expanded plant in response to the rising need for supplies for COVID-19 research.
Few of the players in the cell expansion technologies market include Danaher (US), Corning, Inc. (US), Sartorius Stedim Biotech (France), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Lonza (Switzerland), Terumo Corporation (Japan), Getinge AB (Sweden), and Miltenyi Biotec (Germany).
Regional Classification of the Global Cell Expansion Technologies Market is Described Below:
Middle East and Africa
*Regions and countries are subject to change based on data availability.
Key Elements Included In The Study: Global Cell Expansion Technologies Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.View Methodology